Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ATRA stock hub

Atara Biotherapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ATRAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

71M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ATRA

In the news

Latest news · ATRA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E3.2

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ATRA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001604464
Company name	Atara Biotherapeutics, Inc.
Country	United States
Country code	US
Cusip	046513107
Employees	14
Employees Change	-139%
Employees Change Percent	-90.85
Enterprise value	$72.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-10-16
Isin	US0465132068
Last refreshed	2026-05-10
Market cap	$71M
Market cap category	Micro-Cap
Price	$8.34
Price currency	USD
Rev Per Employee	8,626,571.43x
Sector	Healthcare
Sic	2836
Symbol	ATRA
Website	https://www.atarabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	46.04%
EV Earnings	2.23x
EV Sales Forward	4.24x
EV/EBIT	1.47x
EV/EBITDA	1.41x
EV/Sales	0.6x
FCF yield	-71.75%
P/E ratio	3.25x
P/S ratio	0.59x
PS Forward	4.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.96%
EBITDA Margin	42.71%
Gross margin	61.79%
Gross Profit	$74.6M
Gross Profit Growth Q	-92.41%
Net Income	$32.7M
Net Income Growth Quarters	10%
Net Income Growth Years	2%
Pretax Margin	27.09%
Profit Margin	27.07%
Profit Per Employee	$2.3M
Profitable Years	1
ROA	47.81
Roa5y	-26.18
ROCE	931.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-31.72%
Cagr1y	14.89%
Cagr3y	-51.41%
Cagr5y	-52.36%
EPS Growth Years	2
Revenue Growth	-6.34x
Revenue Growth Q	-95.13x
Revenue Growth Years	0x
Revenue Growth3 Y	23.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.87
Assets	$20.2M
Cash	$8.5M
Current Assets	$12.2M
Current Liabilities	$14.9M
Debt	$10.4M
Debt EBITDA	$0.18
Equity	$-38.5M
Interest Coverage	13.05
Liabilities	$58.7M
Long Term Assets	$8M
Long Term Liabilities	$43.8M
Net Cash	$-1.9M
Net Cash By Market Cap	$-2.67
Net Debt EBITDA	$0.04
Tangible Book Value	$-38.5M
Tangible Book Value Per Share	$-5.26
WACC	6.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.82
Net Working Capital	$-10.2M
Quick ratio	0.65
Working Capital	$-2.7M
Working Capital Turnover	$-3.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-69.85%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-97.8%
1Y total return	14.88%
200-day SMA	10.26
3Y total return	-88.54%
50-day SMA	5.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.55%
All Time High	1,639
All Time High Change	-99.49%
All Time High Date	2015-07-14
All Time Low	3.92
All Time Low Change	112.76%
All Time Low Date	2026-02-23
ATR	0.98
Beta	-0.29
Beta1y	1.44
Beta2y	0.62
Ch YTD	-53.9
High	9.93
High52	19.15
High52 Date	2026-01-05
High52ch	-56.44%
Low	7.85
Low52	3.92
Low52 Date	2026-02-23
Low52ch	112.76%
Ma50ch	57.15%
Premarket Change Percent	-2.82
Premarket Price	$9.65
Premarket Volume	534,054
Price vs 200-day SMA	-18.69%
RSI	68.1
RSI Monthly	38.61
RSI Weekly	51.46
Sharpe ratio	0.76x
Sortino ratio	1.33
Total Return	-69.85%
Tr YTD	-53.9
Tr1m	77.07%
Tr1w	70.2%
Tr3m	70.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Hold
Earnings EPS Estimate	$0.32
Earnings EPS Estimate Growth	-90.86
Earnings Revenue Estimate	2,175,000x
Earnings Revenue Estimate Growth	-97.78x
Operating Income	$49.5M
Operating margin	40.96
Price target	$8.5
Price Target Change	$1.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,162,055%
Float Percent	48.89%
Net Borrowing	-250,000
Shares Insiders	2.32%
Shares Institutions	26.14%
Shares Out	8,512,272
Shares Qo Q	0.42%
Shares Yo Y	69.85%
Short Float	7.64%
Short Ratio	3.32
Short Shares	3.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-60.7M
Average Volume	4,003,600x
Bv Per Share	-5.26
Ch10y	-97.8
Ch1m	77.07
Ch1w	70.2
Ch1y	14.88
Ch3m	70.9
Ch3y	-88.54
Ch5y	-97.55
Ch6m	-29.38
Change	-16.01%
Change From Open	-13.58
Close	9.93
Days Gap	-2.82
Depreciation Amortization	2,116,000
Dollar Volume	25,044,544.6
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$49.5M
EBITDA	$51.6M
EPS	$2.57
F Score	5
FCF	$-50.9M
FCF EV Yield	-69.89x
FCF Per Share	$-5.98
Financing CF	16,098,000
Fiscal Year End	December
Founded	2,012
Income Tax	$31,000
Investing CF	18,148,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Date	2024-06-20
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	9.61
Ma150ch	-13.17%
Ma20	5.4
Ma20ch	54.56%
Net CF	-16,694,000
Next Earnings Date	2026-05-22
Open	9.65
Optionable	No
Position In Range	23.56
Post Close	8.34
Postmarket Change Percent	12.71
Postmarket Price	$9.4
Ppne	7,137,000
Pre Close	9.93
Price Date	2026-05-08
Price EBITDA	$1.38
Relative Volume	0.75x
Revenue	120,772,000x
SBC By Revenue	8.07x
Share Based Comp	9,752,000
Tax By Revenue	0.03x
Tax Rate	0.09%
Tr6m	-29.38%
Us State	California
Volume	3,002,943
Z Score	-125.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ATRA pay a dividend?

Capital-return profile for this ticker.

Performance

ATRA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ATRA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.1%

Float: +48.9% of shares outstanding

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ATRA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.1

Neutral momentum band

Price vs 200-day MA

-18.7%

50/200-day relationship not available

Beta (5Y)

-0.29

Less volatile than the market

Sharpe ratio

0.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ATRA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ATRA stock rating?

Atara Biotherapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ATRA analysis?

The full report lives at /stocks/ATRA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ATRA?

The latest report frames ATRA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ATRA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.